Publizoom

Award notice Supplies

Jaen cbam kern pharma, s.l. am 634/2025

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
Servicio Andaluz de Salud. Hospital Universitario de Jaén.
Jaén
Place of performance
Jaén
Estimated value
€411,345 excl. VAT
Amount awarded
€427,798 excl. VAT
Planned end of contract
3 December 2026
likely re-tender around October 2026
Bids received
1
Procedure
oth-single
Publication
7 October 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

HUJ_1CBAM_AM 634/2025_KERN PHARMA, S.L._SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS XIII I(RELACIONADOS EN EL ANEXO I DEL PPT) PARA LOS CENTROS SANITARIOS QUE INTEGRAN LA CENTRAL PROVINCIAL DE COMPRAS DE JAÉN. (6.6W6SZYW)

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33690000

Winning prices for comparable contracts

A quarter below
€202,502
Median
€425,325
A quarter above
€1,046,198

Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Jaen cbam sanofi aventis, s.a. am 634/2025
Servicio Andaluz de Salud. Hospital Universitario de Jaén. · 7 October 2026
SANOFI AVENTIS, S.A. €369,639
Jaén cbam am 634/2025 kern pharma, s.l.
Servicio Andaluz de Salud. Hospital Universitario de Jaén. · 28 July 2026
KERN PHARMA, S.L. €300,000
Adjudicación del Contrato Específico del Medicamento FUMARATO DE DIROXIMEL, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para la Corporació de Salut del Maresme i la Selva
Corporació de Salut del Maresme i la Selva · 23 October 2026
BIOGEN SPAIN S.L. €332,714
23/S/25/SU/DG/A/AM33 - Medicamentos no exclus. de uso humano Tipo I - Incluidos en el grupo terapéutico M Y N
Dirección General de Recursos Económicos del Servicio Canario de la Salud · 23 October 2026
LABORATORIOS NORMON, S.A.
TEVA PHARMA SLU
TARBIS FARMA S.L.
SUN PHARMA LABORATORIOS, SLU
€463,493
Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de MEDICAMENTOS ANTIRRETROVIRALES del Consorci Sanitari Integral
Consorci Sanitari Integral · 23 October 2026
EMPRESAS ADJUDICADAS EN EL CONTRATO BASADO (homologadas en el acuerdo marco de referencia) €17,802,819

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 692457-2026.